Seminars2.20.24
Life Sciences Lifeline: The Bayh-Dole Act, March-In Rights, and the Impact on Innovation
Late in 2023, the White House released draft guidance outlining proposed factors that an agency may consider, including the “reasonableness of a product’s price,” when deciding whether to exercise its “march-in rights” to federally funded inventions under the Bayh-Dole Act.
Keep Up to Date in a Changing World
Do you want to receive more valuable insights directly in your inbox? Visit our subscription center and let us know what you’re interested in learning more about.
